This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
GE HealthCare reported 1% growth in organic revenues and a slight increase in profitability in its second quarter of 2024. For the period (end-June 30), GE HealthCare had total revenues of $4.839 billion, flat compared with $4.817 billion in the in the same period last year. last year to 15.3% in the second quarter this year.
GE HealthCare (GEHC) reported a 1% growth in existing operation revenues and an increase in profitability in its second quarter of 2024, citing solid performance in its PharmaceuticalDiagnostics segment. On an individual segment basis, GE HealthCare's Imaging segment had flat revenues year over year of $2.22
GE HealthCare is reporting revenue growth for its 2024 fourth quarter and full fiscal year. billion, which the company attributed to advanced visualization solutions (AVS) and pharmaceuticaldiagnostics, with overall strength in the U.S. Revenue for the quarter came to $5.3
milla1cf Tue, 01/23/2024 - 13:50 January 23, 2024 — Bayer announced Nelson Ambrogio as the new Head of the Radiology Business at its Pharmaceuticals Division, effective April 1, 2024. He will report to Stefan Oelrich , Member of the Board of Management, Bayer AG, and President Pharmaceuticals.
CHICAGO -- GE HealthCare (GEHC) brought new CT and MRI scanners and a range of AI software applications to McCormick Place for RSNA 2023. GE HealthCare's new Revolution Ascend CT scanner. GE HealthCare's Signa Champion 1.5-tesla tesla scanner.
Bracco subsidiary Blue Earth Diagnostics has appointed a new CEO. Marco Campione will report to Bracco Imaging CEO Fulvio Renoldi Bracco and will join Blue Earth Diagnostics' board of directors.
milla1cf Wed, 10/11/2023 - 13:24 October 11, 2023 — GE HealthCare today announced an exclusive global licensing agreement with SOFIE Biosciences (SOFIE), a Virginia, U.S.-based based company, to develop, manufacture and commercialize SOFIE’s Gallium-68 and Fluorine-18 labelled diagnostics targeting fibroblast activation protein (FAP).
Campione also joins the Blue Earth Diagnostics Ltd. Board of Directors and will serve as Vice Chair of the Blue Earth Diagnostics Inc. Board of Directors and will serve as Vice Chair of the Blue Earth Diagnostics Inc. Blue Earth Diagnostics, an indirect subsidiary of Bracco Imaging S.p.A., Board of Directors.
christine.book Thu, 03/21/2024 - 10:34 March 21, 2024 — Diagnostic imaging provider US Radiology Specialists has announced that Lee Cooper will become its new Chief Executive Officer (CEO), and that current board member Molly Joseph will become its next Board Chair. Cooper and Joseph will succeed John Perkins , U.S.
GE HealthCare expects to leverage MIM Software’s imaging analytics and digital workflow capabilities across various care areas to accelerate innovation and differentiate its solutions for the benefit of patients and healthcare systems around the world.
milla1cf Tue, 04/02/2024 - 18:51 April 2, 2024 — Less than three months after signing an agreement to acquire MIM Software Inc. , GE HealthCare Technologies Inc. This includes continuing to grow MIM Software’s offerings for end-to-end standardization across large healthcare system fleets.
Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiation oncology.
Participants were asked to answer questions pertaining to the healthcare system as a whole based on their personal experiences and observations. In a specialized field like healthcare, resolving that tension is complex and it starts by listening to those who are at the center of care,” said GE HealthCare President and CEO Peter Arduini.
Currently, when treating metastatic breast cancer patients, oncologists base clinical decisions on diagnostic tools including biopsy results which only represent the sampled area of the tumor. In the U.S., J Natl Compr Canc Netw.
milla1cf Fri, 06/21/2024 - 20:24 June 21, 2024 — GE HealthCare , a leading global medical technology, pharmaceuticaldiagnostics, and digital solutions innovator, and MediView XR Inc., Contact your GE HealthCare or MediView sales representative to learn more.
For pharmaceutical companies and researchers, using this tracer to better understand the mechanism of action - i.e. the effect of immunotherapies on a patient’s immune response to their cancer - could, potentially, enable them to better select patients to participate in clinical trials and bring new immunotherapies to market.
Imagine going in for a diagnostic MRI scan and coming out with a progressive, irreversible, and potentially fatal disease. But grappling with NSF after the fact may be the least troubling issue as healthcare experts scramble to figure out why some patients develop NSF -- and what they can do to prevent NSF from occurring in the first place.
milla1cf Fri, 05/05/2023 - 17:31 May 5, 2023 — The American College of Radiology ( ACR ), Breast Cancer Research Foundation (BCRF) and GE HealthCare announce the enrollment of the first patients in the Contrast-Enhanced Mammography Imaging Screening Trial (CMIST). For more information: www.acr.org References: 1] Breastcancer.org.
Effective monitoring of treatment response is crucial in managing steatotic liver disease, as it allows healthcare providers to adjust therapeutic interventions based on individual patient needs. This is because in approving Rezdiffra, the FDA said a liver biopsy was not needed to begin treatment.
milla1cf Thu, 11/02/2023 - 13:52 November 2, 2023 — GE HealthCare’s Artificial Intelligence ( AI ) models predict patient response to immunotherapies with 70 to 80 percent accuracy [1] , based on a pan-cancer cohort, according to findings to be presented at the Society for Immunotherapy of Cancer ( SITC ) in San Diego, U.S.,
The project is the second funded and supported by NEURii, a global collaboration between the pharmaceutical company Eisai, Gates Ventures, the University of Edinburgh, the medical research charity LifeArc and the national health data science institute Health Data Research UK.
Medical isotopes are essential for a wide range of diagnostic and therapeutic procedures, including cancer treatments and advanced imaging techniques. This collaboration is a significant step forward in our mission to support healthcare providers and patients by providing high-quality medical isotopes.
In this new position, he brings more than 20 years of operational and leadership expertise in the pharmaceutical and life sciences industry to the Company. and global healthcare.” Previous to Catalent, he was Managing Director, North America, with SEQENS CDMO, a global leader in pharmaceutical solutions (CDMO, Generic APIs).
In-Med is supported by seed funding from Sriram Natarajan, Founder & CEO of Molbio Diagnostics. NeuroShield is also the first in the world to provide reference ranges that can be adjusted to age, gender, and ethnicity, setting new standards in healthcare and bringing us closer to precision medicine that is relevant for everyone, everywhere.
Proscia’s Concentriq AP-Dx is a comprehensive diagnostic software solution that immerses pathologists in an intuitive experience for viewing, interpreting, and managing whole slide images and helps to drive confidence and efficiency gains. Reference: 1. NHS England (2017).
produced, non-uranium based Mo-99 for use in diagnostic imaging. The FibroScint program, a collaboration with Capella Imaging, to develop a Tc-99m agent to image fibrin, and collaboration with GE Healthcare to manufacture I-123 capsules are on track for further advancement this year. Commercial U.S. producer of Mo-99.
The recommendation was issued by the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA), the primary body in the European Union responsible for regulating pharmaceuticals. The agent is used at a low dose for MRI liver scans and "meets an important diagnostic need in patients with few alternatives."
ii More information: www.bracco.com VUEWAY injection is now available to order from Bracco Diagnostics Inc. Avoid use of GBCAs in these patients unless the diagnostic information is essential and not available with non-contrasted MRI or other modalities. Manufactured for Bracco Diagnostics Inc. NJ: Bracco Diagnostics Inc.;
Healthcare is a fast-evolving landscape driven by transforming technologies and shifting user requirements. Healthcare must revolve around the needs of the patient or end user. The need for more remotely accessible services like telemedicine and a range of advanced medical devices is accelerating growth across the industry.
Indian government has taken definitive steps towards inclusive healthcare committing to make India healthier and a model to be emulated by the rest of world. Government schemes like ‘Ayushman Bharat,’ allocates funds towards improving healthcare infrastructure in Tier 2 and 3 cities along with rural areas.
Unleashing the power of AI is a game changer in advancing healthcare to improve lives,” Tan added. Paige reports that it has created a cloud-based platform that transforms pathologists’ workflow and increases diagnostic confidence as well as productivity, all on a global scale.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content